Search research articles
Contact Us
Filters
Showing results (331-340 of 383) with videos related to
Page
of 39
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2010
Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure
Gonzague Jourdain, Thor Andrew Wagner, Nicole Ngo-Giang-Huong, et al.
Ebiomedicine
|
April 15, 2021
Corrigendum to 'Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays'
Nuttada Panpradist, Qin Wang, Parker S Ruth, et al.
Ebiomedicine
|
February 14, 2021
Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays
Nuttada Panpradist, Qin Wang, Parker S Ruth, et al.
Journal of Virology
|
April 19, 2019
Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission
Corey A Williams-Wietzikoski, Mary S Campbell, Rachel Payant, et al.
Journal of Clinical Microbiology
|
July 1, 1996
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group
R W Shafer, M A Winters, D L Mayers, et al.
The Journal of Infectious Diseases
|
October 18, 2017
Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014
Rachel A Silverman, Ingrid A Beck, Catherine Kiptinness, et al.
PLOS Global Public Health
|
March 24, 2023
Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya
Justin D Vrana, Nuttada Panpradist, Nikki Higa, et al.
Eclinicalmedicine
|
January 21, 2020
Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
Ingrid A Beck, Molly Levine, Christine J McGrath, et al.
The Lancet. HIV
|
December 11, 2019
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial
Michael H Chung, Christine J McGrath, Ingrid A Beck, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators
W Borkowsky, D Wara, T Fenton, et al.
Page
of 39
Search research articles
Search
Showing results (331-340 of 383) with videos related to
Sort By:
Page
of 39
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2010
Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure
Gonzague Jourdain, Thor Andrew Wagner, Nicole Ngo-Giang-Huong, et al.
Ebiomedicine
|
April 15, 2021
Corrigendum to 'Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays'
Nuttada Panpradist, Qin Wang, Parker S Ruth, et al.
Ebiomedicine
|
February 14, 2021
Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays
Nuttada Panpradist, Qin Wang, Parker S Ruth, et al.
Journal of Virology
|
April 19, 2019
Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission
Corey A Williams-Wietzikoski, Mary S Campbell, Rachel Payant, et al.
Journal of Clinical Microbiology
|
July 1, 1996
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group
R W Shafer, M A Winters, D L Mayers, et al.
The Journal of Infectious Diseases
|
October 18, 2017
Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014
Rachel A Silverman, Ingrid A Beck, Catherine Kiptinness, et al.
PLOS Global Public Health
|
March 24, 2023
Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya
Justin D Vrana, Nuttada Panpradist, Nikki Higa, et al.
Eclinicalmedicine
|
January 21, 2020
Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
Ingrid A Beck, Molly Levine, Christine J McGrath, et al.
The Lancet. HIV
|
December 11, 2019
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial
Michael H Chung, Christine J McGrath, Ingrid A Beck, et al.
The Journal of Infectious Diseases
|
March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators
W Borkowsky, D Wara, T Fenton, et al.
Page
of 39